Table 1. Baseline characteristics and clinicopathological information of the 47 patients who underwent salvage surgery for non-curative ESD.
Age | Range, median (years) | 36–83,71 |
Sex | Male/Female | 34/13 |
Tumor location | Upper/Middle/Lower | 8/22/17 |
Tumor size | Range, median (mm) | 7–49, 17 |
Invasion depth | M/SM1/SM2/MP/SS | 5/7/32/2/1 |
Dominant histology | Differentiated (pap, tub1, tub2) | 34 |
Undifferentiated (por, sig) | 12 | |
Unclassified (muc) | 1 | |
Indications for salvage surgery | SM2 invasion | 35 |
Lymphatic invasion positive | 21 | |
Vertical margin positive | 20 | |
Vascular invasion positive | 16 | |
Horizontal margin positive | 4 | |
Surgical procedure | Total gastrectomy/others | 3/44 |
Postoperative complication | Anastomotic trouble | 3 |
Small bowel obstruction | 2 | |
Pancreatic fistula | 2 | |
Long-term outcome in median | Cancer recurrence | 0 |
follow-up of 4 years | Death (cause) | 2 (pneumonia) |